Antigens & Antibodies
Showing 201–250 of 797 results
![Human Immunodeficiency Virus GP120 Protein [HIV-1/Clade B (89BZ_167)]](https://thenativeantigencompany.com/wp-content/uploads/1970/01/Misc-Virus-33-M-1-300x300.jpg)
Human immunodeficiency virus subtype C, gp140 (SOSIP), untagged
This protein is the soluble part of the human immunodeficiency virus Envelope protein gp160. An estimated 25% of the protein is cleaved into gp120 and the soluble gp41 fraction, 75% are presented as gp140. Oligomeric status is mainly monomeric, with a minority of dimer and trimer.
Human immunodeficiency virus subtype CRF01_AE, gp140 (SOSIP), untagged
Human immunodeficiency virus subtype CRF01_AE glycoprotein 140 (gp140). An estimated 25% of the protein is cleaved into gp120 and the soluble gp41 fraction, 75% are presented as gp140. Oligomeric status is mainly monomeric, with a minority of dimer and trimer.
Human immunodeficiency virus type 2, gp140 (SOSIP), untagged
HIV-2 gp140 produced in HEK293 cells and purified from cultrue supernatant. The protein contains a C-terminal T4 foldon domain to stabilize natural trimers. The furin cleavage site was enhanced from "RHKR" to "RRRRRR" to facilitate furin cleavage. The protein is presented as a mix of cleaved and uncleaved protein.
Human Metapneumovirus (hMPV) 18 Type B2 Lysate
Human metapneumovirus 18 type B2 (Strain: IA18-2003) lysate from LLC-mk2 cell line. Purified by sucrose density gradient ultracentrifugation and heat-inactivated, followed by verification with validated tissue culture infectivity assay. Suitable for the development of immunoassays, Western blotting, dot blotting and other protein-based assays.
Human Metapneumovirus (hMPV) 3 Type B1 Lysate
Human metapneumovirus 3 type B1 (Strain: Peru2-2002) lysate from LLC-mk2 cell line. Purified by sucrose density gradient ultracentrifugation and heat-inactivated, followed by verification with validated tissue culture infectivity assay. Suitable for the development of immunoassays, Western blotting, dot blotting and other protein-based assays.
Human Metapneumovirus (hMPV) 9 Type A1 Lysate
Human metapneumovirus 9 type A1 (Strain: IA3-2002) lysate from LLC-mk2 cell line. Purified by sucrose density gradient ultracentrifugation and heat-inactivated, followed by verification with validated tissue culture infectivity assay. Suitable for the development of immunoassays, Western blotting, dot blotting and other protein-based assays.
Human Metapneumovirus (hMPV) A Glycoprotein G, His-Tag (HEK293)
Human metapneumovirus glycoprotein G ectodomain. The protein was produced in HEK293 cells and purified from culture supernatant. Glycoprotein G attaches the virion to the host cell membrane by interacting with glycosaminoglycans, initiating the infection. It also interacts with host DDX58 and inhibits DDX58-mediated signaling pathway in order to prevent the establishment of the antiviral state.
Human Metapneumovirus (hMPV) B Fusion Glycoprotein F0, His-Tag (HEK293)
Human metapneumovirus glycoprotein F0. The protein was produced in HEK293 cells and purified from culture supernatant. The F glycoprotein mediates virus-cell membrane fusion and is the primary target of neutralizing antibodies.
Human Metapneumovirus (hMPV) B Glycoprotein G, His-Tag (HEK293)
Human Metapneumovirus (hMPV) B glycoprotein G is a recombinant antigen produced in mammalian cells to Glycoprotein G attaches the virion to the host cell membrane by interacting with glycosaminoglycans, initiating the infection. It also interacts with host DDX58 and inhibits DDX58-mediated signaling pathway in order to prevent the establishment of the antiviral state.
Human Parainfluenza Virus Type 3 Lysate
Parainfluenza Virus Type 3 is purified from LLC-mk2 cells using sucrose density gradient ultracentrifugation, disrupted in the presence of detergent and heat inactivated. Viral lysates can be utilized as an antigen, as a source for the purification of viral proteins, or for the detection of viral antibodies.
![Influenza B [B/Palermo/4/2013] Hemagglutinin Parainfluenza Virus Type 4A](https://thenativeantigencompany.com/wp-content/uploads/2020/12/Coronavirus-35-300x300.jpg)
Human Parainfluenza Virus Type 4A Lysate
Parainfluenza Virus Type 4A is purified from LLC-mk2 cells using sucrose density gradient ultracentrifugation, disrupted in the presence of detergent and heat inactivated. Viral lysates can be utilized as an antigen, as a source for the purification of viral proteins, or for the detection of viral antibodies.
Human parainfluenzavirus 3 haemagglutinin-neuraminidase (HN) protein, C-terminal His-tag
Recombinant human Parainfluenza Virus Type 3 haemagglutinin-neuraminidase (HN) protein, manufactured in HEK293 cells.
Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) Envelope Protein, Sheep Fc-Tag (HEK293)
Recombinant human T-cell lymphotropic virus type 1 (HTLV-1) envelope protein. The protein was produced in HEK293 cells and purified to high purity from culture supernatant with a TEV cleavage site and C-terminal sheep Fc-tag.
Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) p24, C-terminal His-tag
HTLV-1 p24, C-terminal His-tag, purified by immobilized metal affinity chromatography, ion exchange chromatography and dialysis, Native Antigen.
Human T-Cell Lymphotropic Virus Type 2 (HTLV-2) Envelope Protein, Sheep Fc-Tag (HEK293)
Recombinant human T-cell lymphotropic virus type 2 (HTLV-2) envelope protein. The protein was produced in HEK293 cells and purified to high purity from culture supernatant with a TEV cleavage site and C-terminal sheep Fc-tag.
Influenza A [A/Cambodia/e0826360/2020 (H3N2)-like virus] Hemagglutinin (HA), His-Tag
This recombinant hemagglutinin protein is derived from the HA sequence of the Influenza A/Cambodia/e0826360/2020 (H3N2)-like virus, expressing (AA) 1-547, and fused with a polyhistidine tag at the C-terminus. It was manufactured in mammalian HEK293 cells as a stable trimer. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2021 - 2022 northern hemisphere influenza season.
Influenza A [A/Cambodia/e0826360/2020 (H3N2)-like virus] Neuraminidase (NA), His-Tag
This recombinant neuraminidase protein is derived from the NA sequence of the Influenza A/Cambodia/e0826360/2020 (H3N2)-like virus, expressing aa 46-469, and fused with a polyhistidine tag at the C-terminus. It was manufactured in mammalian HEK293 cells. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2021 - 2022 northern hemisphere influenza season.
Influenza A [A/Cambodia/NPH230032/2023] Nucleoprotein (NP), HIS-TAG
Influenza A [A/Cambodia/NPH230032/2023] nucleoprotein (NP) is a recombinant antigen expressed and purified from Escherichia coli. Register interest
Influenza A [A/chicken/Scotland/054477/2021] Nucleoprotein (NP), HIS-TAG
Influenza A [A/chicken/Scotland/054477/2021)] nucleoprotein (NP) is a recombinant antigen expressed and purified from Escherichia coli. Register interest
Influenza A [A/Darwin/6/2021 (H3N2)-like virus] Hemagglutinin (HA), His-tag
This Influenza virus Hemagglutinin protein is derived from the HA sequence of the A/Darwin/6/2021 (H3N2)-like virus, fused with a polyhistidine tag at the C-terminus. The influenza virus hemagglutinin protein is expressed in HEK293 cells as a stable trimer. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2022-23 northern hemisphere influenza season.
Influenza A [A/Darwin/6/2021 (H3N2)-like virus] Hemagglutinin (HA), His-tag
This Influenza virus Hemagglutinin protein is derived from the HA sequence of the A/Darwin/6/2021 (H3N2)-like virus, fused with a polyhistidine tag at the C-terminus. The influenza virus hemagglutinin protein is expressed in HEK293 cells as a stable trimer. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2022-23 southern (SH) hemisphere influenza season.
Influenza A [A/Darwin/6/2021 (H3N2)-like virus] Neuraminidase (NA), His-tag
This recombinant neuraminidase protein is derived from the NA sequence of the Influenza A/Darwin/6/2021 (H3N2)-like virus, fused with a polyhistidine tag at the C-terminus. It was manufactured in mammalian HEK293 cells. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2022 - 2023 northern hemisphere influenza season.
Influenza A [A/Darwin/9/2021 (H3N2)-like virus] Hemagglutinin (HA), His-Tag
A recombinant influenza virus hemagglutinin protein derived from the HA sequence of A/Darwin/9/2021 (H3N2)-like virus, expressed and purified from HEK293 cells as (AA) 1-529 as a stable trimer and fused with a polyhistidine tag at the C-terminus. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2022 southern hemisphere influenza season.
Influenza A [A/Darwin/9/2021 (H3N2)-like virus] Neuraminidase (NA), His-Tag
A recombinant influenza virus neuraminidase protein derived from the NA sequence of Influenza A/Darwin/9/2021 (H3N2)-like virus, expressed and purified from HEK293 cells as aa 18-545, and fused with a polyhistidine tag at the C-terminus. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2022 southern hemisphere influenza season.
Influenza A [A/Duck/Egypt/AR526/2017] Nucleoprotein (NP), HIS-TAG
Influenza A [A/Duck/Egypt/AR526/2017] nucleoprotein (NP) is a recombinant antigen expressed and purified from Escherichia coli. Register interest
Influenza A [A/Greylag_goose/England/054503/2021] Nucleoprotein (NP), HIS-TAG
Influenza A [A/Greylag_goose/England/054503/2021] nucleoprotein (NP) is a recombinant antigen expressed and purified from Escherichia coli. Register interest
Influenza A [A/Greylag_goose/Scotland/024915/2022] Nucleoprotein (NP), HIS-TAG
Influenza A [A/Greylag_goose/Scotland/024915/2022] nucleoprotein (NP) is a recombinant antigen expressed and purified from Escherichia coli. Register interest
![Influenza A [A/Guinea Fowl/Hong Kong/WF10/99(H9N2)] Hemagglutinin (HA), His-Tag](https://thenativeantigencompany.com/wp-content/uploads/2016/01/shutterstock_1181475319-300x300.jpg)
Influenza A [A/Guinea Fowl/Hong Kong/WF10/99 (H9N2)] Hemagglutinin (HA), His-Tag
Recombinant Influenza A [A/Guinea fowl/Hong Kong/WF10/99(H9N2)] Hemagglutinin (HA) protein, comprising amino acids 17-531, incorporating a C-terminal 6xHis tag, produced in mammalian HEK293 cells.
![Influenza A [A/Guinea Fowl/Hong Kong/WF10/99 (H9N2)] Hemagglutinin 1 (HA1), His-Tag](https://thenativeantigencompany.com/wp-content/uploads/2016/01/shutterstock_1202681137-300x300.jpg)
Influenza A [A/Guinea Fowl/Hong Kong/WF10/99 (H9N2)] Hemagglutinin 1 (HA1), His-Tag
Recombinant Influenza A [A/Guinea fowl/Hong Kong/WF10/99 (H9N2)] Hemagglutinin 1(HA1) protein comprising amino acids 19-338, incorporating a C-terminal 6xHis tag, produced in mammalian HEK293 cells.
Influenza A [A/Hawaii/70/2019 (H1N1)pdm09-like virus] Hemagglutinin (HA), His-Tag
A recombinant influenza virus hemagglutinin protein derived from the HA sequence of A/Hawaii/70/2019 (H1N1)pdm09-like virus, expressed and purified from HEK293 cells as aa 1-529, and fused with a polyhistidine tag at the C-terminus. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2020 - 2021 northern hemisphere influenza season.
Influenza A [A/Hawaii/70/2019 (H1N1)pdm09-like virus] Neuraminidase (NA), His-Tag
This Influenza virus neuraminidase protein is derived from the NA sequence of the A/Hawaii/70/2019 (H1N1)pdm09-like virus, expressing aa 46-469, and fused with a polyhistidine tag at the C-terminus. The influenza virus neuraminidase protein is expressed in HEK293 cells. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2020 - 2021 northern hemisphere influenza season.
Influenza A [A/Hong Kong/1/1968 (H3N2)], Nucleoprotein (NP), His-Tag
Influenza A [A/Hong Kong/1/1968 (H3N2)] nucleoprotein (NP) is a recombinant antigen expressed and purified from Escherichia coli.
![Influenza A [A/Hong Kong/45/2019 (H3N2)]](https://thenativeantigencompany.com/wp-content/uploads/2020/12/Misc-Virus-122-300x300.jpg)
Influenza A [A/Hong Kong/45/2019 (H3N2)] Hemagglutinin (HA), His-Tag
This Influenza virus hemagglutinin protein is derived from the HA sequence of Influenza A/Hong Kong/45/2019 (H3N2) expressing aa 18-529, and fused with a polyhistidine tag at the C-terminus. The influenza virus hemagglutinin protein is expressed in HEK293 cells. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2020 - 2021 northern hemisphere influenza season.
Influenza A [A/Hong Kong/45/2019 (H3N2)] Neuraminidase (NA), His-Tag
A recombinant influenza virus neuraminidase protein derived from the NA sequence of A/Hong Kong/45/2019 (H3N2), expressed and purified from HEK293 cells as aa 31-468, and fused with a polyhistidine tag at the C-terminus. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2020 - 2021 northern hemisphere influenza season.
![Influenza A [A/Hong Kong/483/97 (H5N1)] Hemagglutinin (HA), His-Tag](https://thenativeantigencompany.com/wp-content/uploads/1970/01/shutterstock_1204546204-300x300.jpg)
Influenza A [A/Hong Kong/483/97 (H5N1)] Hemagglutinin (HA), His-Tag
Recombinant Influenza A [A/Hong Kong/483/97 (H5N1)] Hemagglutinin (HA) protein, comprising amino acids 17-531, incorporating a C-terminal 6xHis tag, produced in mammalian HEK293 cells.
Influenza A [A/Ohio/2017] Neuraminidase (NA), His-Tag
This Influenza virus neuraminidase protein is derived from the NA sequence of the IAV [A/swine/Ohio/17TOSU5163/2017], expressing aa 34-469, and fused with a polyhistidine tag at the C-terminus. The influenza virus neuraminidase protein is expressed in HEK293 cells.
![Influenza A [A/Puerto Rico/8/1934 (H1N1)] Hemagglutinin (HA), His-Tag](https://thenativeantigencompany.com/wp-content/uploads/2016/07/Influenza-Virus-09-300x300.jpg)
Influenza A [A/Puerto Rico/8/1934 (H1N1)] Hemagglutinin (HA), His-Tag
Recombinant Influenza A [A/Puerto Rico/8/1934 (H1N1)] Hemagglutinin (HA) protein, comprising amino acids 1-529, incorporating a C-terminal 6xHis tag, produced in mammalian HEK293 cells.
![Influenza A [A/Shanghai/2/2013(H7N9)] Hemagglutinin (HA), Fc-Tag](https://thenativeantigencompany.com/wp-content/uploads/2016/01/shutterstock_653236915-1-300x300.jpg)
Influenza A [A/Shanghai/2/2013(H7N9)] Hemagglutinin (HA), Fc-Tag
Recombinant Influenza A [A/Shanghai/2/2013(H7N9)] Hemagglutinin (HA) protein, comprising amino acids 19-521, incorporating a C-terminal mouse IgG1 Fc tag, produced in mammalian HEK293 cells.
![Influenza A [A/swine/Shandong/1207/2016] HA](https://thenativeantigencompany.com/wp-content/uploads/2020/12/shutterstock_1716117196-300x300.jpg)
Influenza A [A/swine/Shandong/1207/2016] Hemagglutinin (HA), His-Tag
This Influenza virus hemagglutinin protein is derived from the HA sequence of A/swine/Shandong/1207/2016, expressing aa 18-529, and fused with a polyhistidine tag at the C-terminus. The influenza virus hemagglutinin protein is manufactured in HEK293 cells to This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2020 - 2021 northern hemisphere influenza season.
Influenza A [A/swine/Shandong/1207/2016] Neuraminidase (NA), His-Tag
A recombinant influenza virus neuraminidase protein derived from the NA sequence of A/swine/Shandong/1207/2016, expressed and purified from HEK293 cells as aa 40-469, and fused with a polyhistidine tag at the C-terminus. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2020 - 2021 northern hemisphere influenza season.
Influenza A [A/Sydney/5/2021 (H1N1) pdm09-like virus] Hemagglutinin (HA), His-tag – (recombinant based vaccines)
This Influenza virus Hemagglutinin protein is derived from the HA sequence of the A/Sydney/5/2021 (H1N1) pdm09-like virus, fused with a polyhistidine tag at the C-terminus. The influenza virus hemagglutinin protein is expressed in HEK293 cells as a stable trimer. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2022-23 southern (SH) hemisphere influenza season.
Influenza A [A/Sydney/5/2021 (H1N1) pdm09-like virus] Hemagglutinin (HA), His-tag- (egg based vaccines)
This Influenza virus Hemagglutinin protein is derived from the HA sequence of the A/Sydney/5/2021 (H1N1) pdm09-like virus, fused with a polyhistidine tag at the C-terminus. The influenza virus hemagglutinin protein is expressed in HEK293 cells as a stable trimer. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2022-23 southern (SH) hemisphere influenza season.
Influenza A [A/Sydney/5/2021 (H1N1)pdm09-like virus] Neuraminidase (NA), His-Tag
This Influenza virus Hemagglutinin protein is derived from the HA sequence of the A/Darwin/6/2021 (H3N2)-like virus, fused with a polyhistidine tag at the C-terminus. The influenza virus hemagglutinin protein is expressed in HEK293 cells as a stable trimer. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2022-23 southern (SH) hemisphere influenza season.
![Influenza A [A/Thailand/1(KAN-1)/2004 (H5N1)] Neuraminidase (NA), His-Tag](https://thenativeantigencompany.com/wp-content/uploads/2016/01/shutterstock_593348885-300x300.jpg)
Influenza A [A/Thailand/1(KAN-1)/2004 (H5N1)] Neuraminidase (NA), His-Tag
Recombinant Influenza A [A/Thailand/1(KAN-1)/2004 (H5N1)] Neuraminidase (NA) protein, comprising amino acids 36-449, incorporating an N-terminal 6xHis tag, produced in mammalian HEK293 cells.
Influenza A [A/Victoria/2570/2019 (H1N1)pdm09-like virus] Hemagglutinin (HA), His-Tag
A recombinant influenza virus hemagglutinin protein derived from the HA sequence of Influenza A/Victoria/2570/2019 (H1N1)pdm09-like virus, expressed and purified from HEK293 cells as (AA) 1-528, as a stable trimer and fused with a polyhistidine tag at the C-terminus. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2021 - 2022 northern hemisphere influenza season.
Influenza A [A/Victoria/2570/2019 (H1N1)pdm09-like virus] Hemagglutinin (HA), His-tag
This Influenza virus Hemagglutinin protein is derived from the HA sequence of the A/Victoria/2570/2019 (H1N1)pdm09-like virus, fused with a polyhistidine tag at the C-terminus. The influenza virus hemagglutinin protein is expressed in HEK293 cells as a stable trimer. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2022-23 northern hemisphere influenza season.
Influenza A [A/Victoria/2570/2019 (H1N1)pdm09-like virus] Neuraminidase (NA), His-Tag
A recombinant influenza virus neuraminidase protein derived from the NA sequence of Influenza A/Victoria/2570/2019 (H1N1)pdm09-like virus, expressed and purified from HEK293 cells as aa 1-529, and fused with a polyhistidine tag at the C-terminus. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2021 - 2022 northern hemisphere influenza season.
Influenza A [A/Victoria/4897/2022 (H1N1) pdm09-like virus] Hemagglutinin (HA), His-tag – (recombinant based vaccines)
This Influenza virus Hemagglutinin protein is derived from the HA sequence of the A/Victoria/4897/2022 (H1N1) pdm09-like virus, fused with a polyhistidine tag at the C-terminus. The influenza virus hemagglutinin protein is expressed in HEK293 cells as a stable trimer. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the norther hemisphere 2023/2024 influenza season.
Influenza A [A/Victoria/4897/2022 (H1N1)pdm09-like virus] Neuraminidase (NA),His-Tag
This Influenza virus Neuraminidase protein is derived from the NA sequence of the A/Victoria/4897/2022 (H1N1)-like virus, fused with a polyhistidine tag at the C-terminus. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the norther hemisphere 2023/2024 hemisphere influenza season.
Influenza A [A/Wisconsin/588/2019 (H1N1)pdm09-like virus] Hemagglutinin (HA), His-Tag
A recombinant influenza virus hemagglutinin protein derived from the HA sequence of Influenza A/Wisconsin/588/2019 (H1N1)pdm09-like virus, expressed and purified from HEK293 cells as aa 1-528, and fused with a polyhistidine tag at the C-terminus. This virus is recommended by WHO for inclusion in the quadrivalent and trivalent vaccines for use in the 2022 southern hemisphere influenza season.
Powered by Bioz